Toward detailed, personalized maps of identified and interpreted genomic variation
S6K1 pathway could be a promising therapeutic target
Understanding resistance in PARP inhibitor therapy
Two new studies add insights and home in on therapeutic targets
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Understanding the role of nitric oxide and hyaluronan in asthma
Discovery of new MS subtype suggests that the axon itself may be primary site of injury
Dr. Jianjun Zhao receives two-year grant
PON2 associated with high-density lipoprotein
Research has clear implications for future of prostate cancer imaging
Investigating a gene tied to both cancer and autism
Advertisement
Advertisement